×
About 2,956 results

ALLMedicine™ Mucormycosis Center

Research & Reviews  1,417 results

Pulmonary mucormycosis in immunocompetent hosts diagnosed by bronchioalveolar lavage.
https://doi.org/10.1136/bcr-2020-240180
BMJ Case Reports; Kumar S, Joshi D

Apr 13th, 2021 - Mucormycosis is a rare infection caused by Mucorales fungi belonging to Zygomycetes class. It can present with spectrum of symptoms and signs based of organ involvement. Common forms of mucormycosis includes rhinocerebral, cutaneous, gastrointesti...

Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
https://doi.org/10.1177/11206721211009450
European Journal of Ophthalmology; Veisi A, Bagheri A et. al.

Apr 12th, 2021 - To report two cases of COVID-19 under treatment with a corticosteroid; in one case rhino-orbitocerebral mucormycosis and in another one rhino-orbital mucormycosis developed. A 40-year old woman and a 54-year old man with severe COVID-19 underwent ...

Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
https://doi.org/10.1017/S0022215121000992
The Journal of Laryngology and Otology; Sharma S, Grover M et. al.

Apr 8th, 2021 - Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.|2021|Sharma S,Grover M,Bhargava S,Samdani S,Kataria T,|

Pulmonary and cutaneous mucormycosis in two children with diabetes mellitus type 1.
https://doi.org/10.1515/jpem-2020-0623
Journal of Pediatric Endocrinology & Metabolism : JPEM; Ghaemi N, Bagheri S et. al.

Apr 5th, 2021 - Mucormycosis is a life-threatening condition that can be present in diabetes mellitus. Although the rhino-orbito-cerebral form is the most common, other types may be developed as well. The present study reports two children with diabetes who had t...

Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Ima...
https://doi.org/10.1093/cid/ciaa1855
Clinical Infectious Diseases : an Official Publication Of... Alexander BD, Lamoth F et. al.

Mar 12th, 2021 - Clinical imaging in suspected invasive fungal disease (IFD) has a significant role in early detection of disease and helps direct further testing and treatment. Revised definitions of IFD from the EORTC/MSGERC were recently published and provide c...

see more →

Guidelines  5 results

Global guideline for the diagnosis and management of mucormycosis: an initiative of the...
https://doi.org/10.1016/S1473-3099(19)30312-3
The Lancet. Infectious Diseases; Cornely OA, Alastruey-Izquierdo A et. al.

Nov 8th, 2019 - Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidiscipl...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 24th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infec...
https://doi.org/10.1111/1469-0691.12569
Clinical Microbiology and Infection : the Official Public... Cornely OA, Cuenca-Estrella M et. al.

Mar 12th, 2014 - This guideline is the second in the line of three for fungal diseases by ESCMID and other societies. The guideline tried to follow the AGREE criteria for the development of clinical guidelines. This guideline serves as a European and potentially w...

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormyco...
https://doi.org/10.1111/1469-0691.12371
Clinical Microbiology and Infection : the Official Public... Cornely OA, Arikan-Akdagli S et. al.

Jan 31st, 2014 - These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management of mucormycosis. Only a few of the numerous recommendations can...

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: gu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659979
Haematologica Skiada A, Lanternier F et. al.

Sep 17th, 2012 - Mucormycosis is an emerging cause of infectious morbidity and mortality in patients with hematologic malignancies. However, there are no recommendations to guide diagnosis and management. The European Conference on Infections in Leukemia assigned ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  1,467 results

Pulmonary mucormycosis in immunocompetent hosts diagnosed by bronchioalveolar lavage.
https://doi.org/10.1136/bcr-2020-240180
BMJ Case Reports; Kumar S, Joshi D

Apr 13th, 2021 - Mucormycosis is a rare infection caused by Mucorales fungi belonging to Zygomycetes class. It can present with spectrum of symptoms and signs based of organ involvement. Common forms of mucormycosis includes rhinocerebral, cutaneous, gastrointesti...

Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
https://doi.org/10.1177/11206721211009450
European Journal of Ophthalmology; Veisi A, Bagheri A et. al.

Apr 12th, 2021 - To report two cases of COVID-19 under treatment with a corticosteroid; in one case rhino-orbitocerebral mucormycosis and in another one rhino-orbital mucormycosis developed. A 40-year old woman and a 54-year old man with severe COVID-19 underwent ...

Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
https://doi.org/10.1017/S0022215121000992
The Journal of Laryngology and Otology; Sharma S, Grover M et. al.

Apr 8th, 2021 - Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.|2021|Sharma S,Grover M,Bhargava S,Samdani S,Kataria T,|

Pulmonary and cutaneous mucormycosis in two children with diabetes mellitus type 1.
https://doi.org/10.1515/jpem-2020-0623
Journal of Pediatric Endocrinology & Metabolism : JPEM; Ghaemi N, Bagheri S et. al.

Apr 5th, 2021 - Mucormycosis is a life-threatening condition that can be present in diabetes mellitus. Although the rhino-orbito-cerebral form is the most common, other types may be developed as well. The present study reports two children with diabetes who had t...

Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Ima...
https://doi.org/10.1093/cid/ciaa1855
Clinical Infectious Diseases : an Official Publication Of... Alexander BD, Lamoth F et. al.

Mar 12th, 2021 - Clinical imaging in suspected invasive fungal disease (IFD) has a significant role in early detection of disease and helps direct further testing and treatment. Revised definitions of IFD from the EORTC/MSGERC were recently published and provide c...

see more →

News  65 results

Nonadherent Diabetes Patients: An Unexpected Group
https://www.mdedge.com/fedprac/article/195699/diabetes/nonadherent-diabetes-patients-unexpected-group?channel=94
Jan Dyer

Mar 11th, 2019 - “Time-specific” dosing of insulin can be an obstacle to adherence for patients with complicated, busy lives. More than half of patients with type 2 diabetes do not achieve their target HbA 1c of 7% after insulin is added to their treatment regimen.

Diabetic Ketoacidosis Takes a Turn for the Worse
https://www.mdedge.com/fedprac/article/166077/diabetes/diabetic-ketoacidosis-takes-turn-worse

May 17th, 2018 - Diabetic ketoacidosis (DKA) is life threatening, but preventable. It was good news that between 2000-2009, rates of DKA began to decline, but researchers from the Centers for Disease Control and Prevention (CDC) say it is “concerning” to find that.

Ibrutinib linked to invasive fungal infections
https://www.mdedge.com/hematology-oncology/article/160284/cll/ibrutinib-linked-invasive-fungal-infections/page/0/1

Mar 7th, 2018 - Based on this finding and on case reports of invasive infections in other patients being treated with ibrutinib, the authors conducted a retrospective survey of centers in the French Innovative Leukemia Organization CLL group. They identified 33 c.

Pulmonary Mucormycosis in a Patient With Uncontrolled Diabetes
https://www.mdedge.com/fedprac/article/155762/diabetes/pulmonary-mucormycosis-patient-uncontrolled-diabetes/page/0/2

Jan 19th, 2018 - Treatments Recently described therapy advancements have indicated improved outcomes. 7 Nevertheless, prognosis remains universally poor with 65% to 70% mortality for patients with cases of isolated pulmonary mucormycosis.

January 2018 Digital Edition
https://www.mdedge.com/fedprac/article/157133/january-2018-digital-edition

Jan 2nd, 2018 - Click here to access the January 2018 Digital Edition. Table of Contents Impact of Drug Shortages on Patient Safety and Pharmacy Operation Costs Pulmonary Mucormycosis in a Patient With Uncontrolled Diabetes Pilot Inpatient Pain Pharmacist Consult.

see more →